ANTX holders · CITADEL ADVISORS LLC 13F · ANTX stock
CITADEL ADVISORS LLC AN2 Therapeutics Inc (ANTX) 13F holding
CITADEL ADVISORS LLC reported 155,239 ANTX shares valued at $530.9K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest ANTX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the ANTX holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 155,239 | $530.9K | COM |
| 2025-12-31 | 115,536 | $131.7K | COM |
| 2025-09-30 | 23,013 | $29.2K | COM |
| 2025-06-30 | 12,497 | $13.2K | COM |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.